Enhancing care for mood disorders

Partner with us to build the clinical evidence based solution for you and your patients.

Participer à l'étude

Benefits of remote monitoring for mood disorders scientifically proven by studies

Higher depression remission rate at 6 months (1)

Lower duration and severity of manic episodes at 2 years (2)

Better overall physical health at 6 months (3)

Edra Care_102

Multicentric Randomized Control Trial

Enrollement

600+ patients treated for a major depressive episode with a primary diagnosis of mood disorder

duration

18 months

OBJECTIVE

Evaluate the budgetary, clinical, and organizational impact of using the Edra telemonitoring system, while analyzing the adherence of patients and healthcare professionals to its use
CENTERS
> 30 centers
Principal Investigators
Pr. Antoine Yrondi
CHU de Toulouse
A comprehensive solution

Remote patient care for depressive and bipolar disorders

Edra develops a complete solution combining two products to provide a periodic and longitudinal follow-up for a comprehensive and personalized care approach.

For healthcare professionnals

A remote patient monitoring platform that enables healthcare professionals to evaluate treatment efficacy and enhance patient follow-up and care. With real-time data collection, symptom questionnaires, and passive data from digital phenotyping, clinicians can promptly identify patients in need of additional support or treatment plans adjustments. This ensure a more responsive and effective care.

For patients

Through a mobile app, patients track and share symptoms with their healthcare team while accessing expert-validated resources tailored to their condition. This personalized content helps patients better understand and manage their disorder supporting their care journey and promoting autonomy and well-being.

Learn more

EDRA IS

A remote patient care solution for depressive and bipolar disorders

THEY TRUST US

Our story

Edra BY RESILIENCE

In February 2021, Resilience was born out of the desire to define a new approach to patient care.

Thanks to the expertise we have acquired in oncology, as the first remote patient monitoring medical device to receive a full approval in France by the Haute Autorité de Santé, we are now expanding our focus to the field of psychiatry.
‍
Deeply convinced psychiatry deserves precision medicine, we believe remote patient monitoring, therapeutic education and supportive care can improve care pathways and better support healthcare professionals in managing their patients. This is how Edra was born.
‍
By placing data at the core of our approach, we aim to provide a comprehensive and personalized care pathway for patients facing mood disorders.

About Resilience

Sources
1 – Yeung et al. 20122 – Simon et al. 2006 3 – Ross et al. 2008

Resilience 2024 © All rights reserved.

This medical device is currently undergoing clinical trials and is not covered by the CE mark. It may only be used in the context of clinical research in accordance with current regulations. Resilience, RCS of Paris under number 893 834 713’.